Abbott starts trial to evaluate new Esprit BTK drug-eluting resorbable scaffold
September 4, 2020 – Abbott (Abbott Park, IL) announced the start of the LIFE-BTK clinical trial to evaluate the safety and effectiveness of the company’s…
Abbott
Abbott’s FreeStyle Libre 2 iCGM system now available to Medicare beneficiaries
September 1, 2020 – Abbott (Abbott Park, IL) announced its next-generation FreeStyle Libre 2 integrated continuous glucose monitoring (iCGM) system is now available to Medicare…
Quidel provides business update, isn’t concerned by Abbott’s new SARS antigen test
August 28, 2020 – Quidel Corporation (San Diego, CA) yesterday announced business updates and reaffirmed that it is “an industry leader in the introduction of…
Abbott releases fast, $5 COVID-19 antigen test, free mobile app to display test results
August 27, 2020 – Abbott (Abbott Park, IL) has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its BinaxNOW…
Abbott releases new research on challenges of caring for cardiovascular patients
August 19, 2020 – New global research released by Abbott (Abbott Park, IL) takes a deep dive into the barriers of cardiovascular patient care and…
Abbott announces start of study to evaluate new device to treat recurrent AFib
August 04, 2020 – Abbott (Abbott Park, IL) announced first enrollments in the TactiFlex PAF IDE study to evaluate a new device to treat people…